| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $23.18M | -50,000 | |
| CEO | 2.07M | $7.87M | - | |
| Dir | 1.48M | $5.60M | - | |
| CFO | 1.07M | $4.07M | - | |
| Other | 1.04M | $3.96M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | Shafique Virani70 | Chief Business Officer | Sale+OE10b5-1 | 18,000 | $6.30 | $113,400.00 | -11.4% | +64.3% | +1.8% | |
| Oct 11, 2023 | Michael Secora74 | Chief Financial Officer | Sale+OE10b5-1 | 50,000 | $6.96 | $348,075.00 | -5.2% | +96.5% | -9.4% | |
| Oct 4, 2023 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 59,794 | $7.21 | $431,025.05 | -6.6% | +37.8% | -15.4% | |
| Oct 3, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $7.29 | $64,777.87 | -0.1% | +33.6% | -17.3% | |
| Sep 28, 2023 | Tina Marriott Larson73 | President and COO | Sale+OE10b5-1 | 3,000 | $7.72 | $23,159.40 | -0.7% | +37.7% | -10.2% | |
| Sep 19, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $8.36 | $74,277.71 | -0.1% | +12.0% | -18.1% | |
| Sep 15, 2023 | Shafique Virani70 | Chief Business Officer | Sale+OE10b5-1 | 18,000 | $8.66 | $155,880.00 | -11.4% | +11.2% | -23.3% | |
| Sep 13, 2023 | Michael Secora74 | Chief Financial Officer | Sale+OE10b5-1 | 50,000 | $8.56 | $427,950.00 | -5.3% | -13.5% | -24.4% | |
| Sep 6, 2023 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 58,765 | $8.81 | $517,441.98 | - | -21.5% | -31.8% | |
| Sep 5, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $8.79 | $78,136.47 | -0.1% | -14.8% | -29.9% |